Keyphrases
Bcl-xL
100%
B-cell Lymphoma 2 (Bcl-2)
100%
Endothelial Cells
100%
Angiogenic
100%
CXC Ligands
26%
Angiogenesis
20%
Human Dermal Microvascular Endothelial Cells (HDMECs)
20%
Vascular Endothelial Growth Factor
13%
Epidermal Growth Factor
13%
Clinical Outcomes
6%
Mitogen-activated Protein Kinase
6%
Apoptosis
6%
Complex Interplay
6%
Chemokines
6%
Control Cell
6%
Receptor 2
6%
Capillary
6%
Induced Expression
6%
Patients with Cancer
6%
Vascular Endothelial Growth Factor Expression
6%
ERK Pathway
6%
Signaling Molecules
6%
Vascular Endothelial Growth Factor Receptor (VEGFR)
6%
Inducer
6%
RNA Interference
6%
Vector Control
6%
Growth Factor Receptor Signaling
6%
Capillary Sprouting
6%
Angiogenic Signaling
6%
L-functions
6%
CXC Receptors
6%
Primary Endothelial Cells
6%
Autocrine Loop
6%
Bcl-2 Family
6%
Pharmacology, Toxicology and Pharmaceutical Science
Vasculotropin
100%
Epidermal Growth Factor
66%
Receptor
33%
Malignant Neoplasm
33%
Mitogen Activated Protein Kinase
33%
Vasculotropin Receptor
33%
CXCL1 Chemokine
33%
Immunology and Microbiology
Bcl-2
100%
Vasculotropin
40%
Upregulation
30%
Angiogenesis
30%
Capillary
20%
Epidermal Growth Factor
20%
Downregulation
10%
Mitogen
10%
Sprouting
10%
Sprout
10%
Dermal Microvascular Endothelial Cell
10%
RNA Interference
10%
CXCL1 Chemokine
10%
Biochemistry, Genetics and Molecular Biology
Bcl-2
100%
Upregulation
33%
Angiogenesis
33%
Vascular Endothelial Growth Factor
33%
Epidermal Growth Factor
22%
Downregulation
11%
Chemokine
11%
extracellular signal regulated kinase
11%
VEGF Receptors
11%
Bcl-2 Family
11%
RNA Interference
11%
Sprouting
11%